Importer of Controlled Substances Application: Noramco, Inc., 95640 [2016-31281]
Download as PDF
<![CDATA[
95640
Federal Register / Vol. 81, No. 249 / Wednesday, December 28, 2016 / Notices
Controlled substance
Drug code
Codeine ...........................................................................................................................................................................
Oxycodone .......................................................................................................................................................................
Hydromorphone ...............................................................................................................................................................
Hydrocodone ...................................................................................................................................................................
Morphine ..........................................................................................................................................................................
The company plans to manufacture
bulk controlled substances for use in
product development and for
distribution to its customers.
Dated: December 20, 2016.
Louis J. Milione,
Assistant Administrator.
[FR Doc. 2016–31284 Filed 12–27–16; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Importer of Controlled Substances
Application: Noramco, Inc.
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration in
accordance with 21 CFR 1301.34(a) on
DATES:
or before January 27, 2017. Such
persons may also file a written request
for a hearing on the application
pursuant to 21 CFR 1301.43 on or before
January 27, 2017.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DRW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for hearing must be
sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for hearing
should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/LJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DRW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
Comments and request for hearing on
applications to import narcotic raw
material are not appropriate. 72 FR 3417
(January 25, 2007).
The
Attorney General has delegated her
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers
importers, and exporters of, controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Diversion
Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.34(a), this is notice that on October
14, 2016, Noramco, Inc., 1440 Olympic
Drive, Athens, Georgia 30601 applied to
be registered as an importer of the
following basic classes of controlled
substances:
Drug code
Phenylacetone .................................................................................................................................................................
Thebaine ..........................................................................................................................................................................
Poppy Straw Concentrate ...............................................................................................................................................
Tapentadol .......................................................................................................................................................................
sradovich on DSK3GMQ082PROD with NOTICES
[FR Doc. 2016–31281 Filed 12–27–16; 8:45 am]
BILLING CODE 4410–09–P
18:54 Dec 27, 2016
[Docket No. DEA–392]
Bulk Manufacturer of Controlled
Substances Application: Navinta LLC
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration in
accordance with 21 CFR 1301.33(a) on
or before February 27, 2017.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DRW, 8701
Morrissette Drive, Springfield, Virginia
22152.
DATES:
Dated: December 19, 2016.
Louis J. Milione,
Assistant Administrator.
VerDate Sep<11>2014
Drug Enforcement Administration
ACTION:
Jkt 241001
PO 00000
Frm 00086
Fmt 4703
Sfmt 4703
8501
9333
9670
9780
Schedule
II
II
II
II
The
Attorney General has delegated her
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Deputy Assistant
Administrator of the DEA Office of
Diversion Control (‘‘Deputy Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.33(a), this is notice that on
September 19, 2016, Navinta LLC, 1499
SUPPLEMENTARY INFORMATION:
DEPARTMENT OF JUSTICE
II
II
II
II
II
SUPPLEMENTARY INFORMATION:
Controlled substance
The company plans to import
thebaine derivatives (9333) as reference
standards. The company plans to import
an intermediate form of tapentadol
(9780) to bulk manufacture tapentadol
for distribution to its customers. The
company plans to import phenylacetone
(8501) and poppy straw concentrate
(9670) to manufacture other controlled
substances.
9050
9143
9150
9193
9300
Schedule
E:\FR\FM\28DEN1.SGM
28DEN1
]]>Agencies
[Federal Register Volume 81, Number 249 (Wednesday, December 28, 2016)]
[Notices]
[Page 95640]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-31281]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Importer of Controlled Substances Application: Noramco, Inc.
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic classes, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration in accordance with 21 CFR
1301.34(a) on or before January 27, 2017. Such persons may also file a
written request for a hearing on the application pursuant to 21 CFR
1301.43 on or before January 27, 2017.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DRW,
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for
hearing must be sent to: Drug Enforcement Administration, Attn:
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All
requests for hearing should also be sent to: (1) Drug Enforcement
Administration, Attn: Hearing Clerk/LJ, 8701 Morrissette Drive,
Springfield, Virginia 22152; and (2) Drug Enforcement Administration,
Attn: DEA Federal Register Representative/DRW, 8701 Morrissette Drive,
Springfield, Virginia 22152. Comments and request for hearing on
applications to import narcotic raw material are not appropriate. 72 FR
3417 (January 25, 2007).
SUPPLEMENTARY INFORMATION: The Attorney General has delegated her
authority under the Controlled Substances Act to the Administrator of
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority
to exercise all necessary functions with respect to the promulgation
and implementation of 21 CFR part 1301, incident to the registration of
manufacturers, distributors, dispensers importers, and exporters of,
controlled substances (other than final orders in connection with
suspension, denial, or revocation of registration) has been redelegated
to the Assistant Administrator of the DEA Diversion Control Division
(``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0,
appendix to subpart R.
In accordance with 21 CFR 1301.34(a), this is notice that on
October 14, 2016, Noramco, Inc., 1440 Olympic Drive, Athens, Georgia
30601 applied to be registered as an importer of the following basic
classes of controlled substances:
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
Phenylacetone...................... 8501 II
Thebaine........................... 9333 II
Poppy Straw Concentrate............ 9670 II
Tapentadol......................... 9780 II
------------------------------------------------------------------------
The company plans to import thebaine derivatives (9333) as
reference standards. The company plans to import an intermediate form
of tapentadol (9780) to bulk manufacture tapentadol for distribution to
its customers. The company plans to import phenylacetone (8501) and
poppy straw concentrate (9670) to manufacture other controlled
substances.
Dated: December 19, 2016.
Louis J. Milione,
Assistant Administrator.
[FR Doc. 2016-31281 Filed 12-27-16; 8:45 am]
BILLING CODE 4410-09-P
